The Blueprint Pioneer Faces Chronic Stomach Condition
The 48-year-old biotech entrepreneur revealed that his immune system is actively attacking his stomach lining, describing the condition as his stomach "eating itself". Johnson noted that Autoimmune Gastritis (AIG) affects an estimated 2 to 5 percent of the global population, though many cases remain undiagnosed due to asymptomatic early stages.
The diagnosis answers a decade-long medical mystery regarding Johnson's chronically low ferritin levels, which persisted despite rigorous dietary management and heavy supplementation. The breakthrough came during a comprehensive evaluation under his $1 million healthcare protocol, where medical tests and tissue biopsies revealed elevated anti-parietal cell antibodies.
Read Also
AIG destroys the stomach cells responsible for producing gastric acid and intrinsic factor, a protein vital for absorbing vitamin B12. "The earliest clue, low ferritin, is frequently overlooked by standard medicine," Johnson stated, noting that the condition is rarely investigated until it progresses to severe anemia or increases gastric cancer risks.
To manage the disease, Johnson received a 1,000 mg intravenous iron infusion and plans to initiate experimental protocols involving immune profiling and engineered cell therapies. The "Blueprint" founder urged the public to pursue proactive health monitoring, emphasizing that the absence of symptoms does not guarantee total wellness.